Find an expert
Our panel of editors and experts are available for interview
Ian Mulvany
Chief Technology Officer, BMJ Group
Since joining BMJ Group in 2020 during the pandemic, Ian has led a sweeping digital transformation, strengthening the organisation’s infrastructure, accelerating its adoption of cloud-based platforms, and embedding AI and automation to improve delivery. Ian has a long track record of driving innovation in research technology. At SAGE Publishing, he founded SAGE Ocean, an incubator advancing new methods for social science research using big data. Earlier roles include Head of Technology at eLife Sciences, Head of Product at Mendeley, and Product Manager at Nature Publishing Group. He has also consistently advocated for open science, serving on the board of Dryad and the editorial board of the Journal of Open Research Software.
A recognised thought leader on digital transformation and AI in publishing, Ian has spoken at The London Book Fair, ALPSP, STM Week, and the International Association of Scientific, Technical and Medical Publishers (STM), as well as in podcasts and webinars on the future of open research, data, and AI adoption.
He regularly shares his reflections on technology, research, and innovation on his personal blog: mulvany.net
.
Theodora Bloom
Executive Editor of the BMJ
Theodora Bloom is executive editor of The BMJ. At the BMJ, Theo’s responsibilities include publishing, business, platform and operations as well as ethical and policy matters. She is a Co-Founder of the medRxiv preprint server, a collaboration between BMJ, Cold Spring Harbor Laboratory and Yale University, and jointly coordinates open access and open research initiatives at BMJ.
Professor Ronald F. van Vollenhoven
Editor-in-Chief of Lupus Science & Medicine
Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.
Professor Juan Víctor Ariel Franco
Editor-in-Chief of BMJ Evidence-Based Medicine
Professor Juan Franco is a family doctor at the Hospital Italiano de Buenos Aires, Argentina, and Vice-chair of the Research Department at the Instituto Universitario Hispital Italiano (IUHI), where he is also Director of the Cochrane Associate Centre. He is a professor at IUHI and Universidad Nacional de La Matanza, and editor for the Cochrane Urology Group and a member of Cochrane’s Governing Board.
Dr James Cave
Editor-in-Chief of the Drugs and Therapeutics Bulletin
Dr James Cave has been a GP for over 25 years. He currently works for Red Whale, providing courses for GP’s that take the latest research and demonstrate how it might be used in practice. James was awarded an OBE for services to medicine in 2009.
Karen L Furie, MD
Editor-in-Chief of the Journal of Neurology, Neurosurgery and Psychiatry
Karen Furie, MD, MPH is Neurologist-in-Chief, Rhode Island Hospital, the Miriam Hospital and Bradley Hospital Samuel I Kennison, MD and Bertha S Kennison Professor of Clinical Neuroscience Chair of Neurology, the Warren Alpert Medical School of Brown University. Clinical and translational stroke research has been a major focus of Karen’s career, and she has enjoyed success in developing collaborative multispecialty initiatives.
